Relationship between changes in postprandial glucagon, patient characteristics, and response to lixisenatide as add-on to oral antidiabetics
- Clifford J. Bailey
- , S.T. Azar
- , Lawrence Blonde
- , D. Dicker
- , M Puig-domingo
- , F.G. Eliaschewitz
- , E. Nikonova
- , R. Roussel
- , K Sakaguchi
- , L Sauque-Reyna
- , M. Nauck
- American University of Beirut
- Hasharon Hospital, Rabin Medical Centre, Petah Tiqwa, Israel
- Universitat Autònoma de Barcelona
- CPClin Clinical Research Center, São Paulo, Brazil ; Albert Einstein Hospital, São Paulo, Brazil.
- Sanofi, Diabete Divion, Global Medical Afairs, Bridgewater, MA USA
- Université Paris Diderot
- Kobe University, 1-1, Rokkodai-cho, Nada-ku, Kobe, 657-8501, JAPAN
- Instituto de Diabetes, Obesidad Y Nutricion S.C., Calle Virginia Hernandez #118. Col. Emiliano Zapata, Virginia Hernández 118, Emiliano Zapata, Cuautla, Mor., Mexico
- Diabeteszentrum, Herz-und Diabeteszentrum NRW
- Ochsner Medical Center
Research output: Contribution to journal › Conference abstract › peer-review
3
Link opens in a new tab
Citations
(Scopus)